These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34594859)

  • 1. National Proficiency Testing of Molecular Diagnostics for Tuberculosis and Drug Resistance Detection - China, 2014-2019.
    Ou X; Xia H; Wang S; Zhao B; Fan J; Song Y; Zhou Y; Zheng Y; Zhao Y
    China CDC Wkly; 2021 Mar; 3(12):247-251. PubMed ID: 34594859
    [No Abstract]   [Full Text] [Related]  

  • 2. External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.
    Nikolayevskyy V; Hillemann D; Richter E; Ahmed N; van der Werf MJ; Kodmon C; Drobniewski F; Ruesch-Gerdes S;
    PLoS One; 2016; 11(4):e0152926. PubMed ID: 27055064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory.
    Kabugo J; Namutebi J; Mujuni D; Nsawotebba A; Kasule GW; Musisi K; Kigozi E; Nyombi A; Lutaaya P; Kangave F; Joloba ML
    PLoS One; 2021; 16(5):e0251691. PubMed ID: 33989348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of External Quality Assurance on the Quality of Xpert MTB/RIF Testing in Viet Nam.
    Gumma V; DeGruy K; Bennett D; Nguyen Thi Kim T; Albert H; Bond KB; Gutreuter S; Alexander H; Ngyuen Thi Phong L; Rush TH; Nguyen Viet N; Nguyen Van H
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microbiological diagnosis of tuberculosis in Serbia in the period 2001-2003].
    Savić B; Vuković D; Dakić I; Kurucin T; Vukelić A
    Med Pregl; 2006; 59(9-10):495-8. PubMed ID: 17345830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.
    Drobniewski FA; Nikolayevskyy V; Hoffner S; Pogoryelova O; Manissero D; Ozin AJ
    Euro Surveill; 2008 Mar; 13(12):. PubMed ID: 18761994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Tuberculosis Control Programme of Liberia Laboratory Programme Performance.
    Desta KT; Masango TE; Zethu Nkosi Z
    J Environ Public Health; 2019; 2019():5340263. PubMed ID: 31360175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and challenges of molecular diagnostics for childhood tuberculosis.
    Gutierrez C
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S4-S5. PubMed ID: 28043600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proficiency panel testing--a reliable tool in external quality assessment of sputum smear microscopy services in Gujarat, India.
    Dave PV; Patel ND; Rade K; Solanki RN; Patel PG; Patel P; Joshi N; Modi B; Pujara K
    Indian J Tuberc; 2011 Jul; 58(3):113-9. PubMed ID: 21941950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
    Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China.
    Ou X; Xia H; Li Q; Pang Y; Wang S; Zhao B; Song Y; Zhou Y; Zheng Y; Zhang Z; Zhang Z; Li J; Dong H; Chi J; Zhang J; Kam KM; Huan S; Jun Y; Chin DP; Zhao Y
    Int J Infect Dis; 2015 Feb; 31():41-6. PubMed ID: 25447720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.
    Du J; Shu W; Liu Y; Wang Y; Zhan Y; Yu K; Gao J; Li L; Pang Y
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1961-1968. PubMed ID: 31342215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV; Malakhov VN; Hoffner SE; Haile M; Wright A
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proficiency testing for HIV, tuberculosis and malaria diagnosis in clinical laboratories in Nigeria.
    Audu RA; Onubogu CC; Okoye RN; Nwokoye NN; Onwuamah CK; Musa AZ; Raheem TY; Aniedobe MN; Nduaga SJ; Essien IO; Idigbe EO
    Afr J Lab Med; 2014; 3(1):102. PubMed ID: 29043176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China.
    Liu Z; Pan A; Wu B; Zhou L; He H; Meng Q; Chen S; Pang Y; Wang X
    Trop Med Int Health; 2017 Oct; 22(10):1328-1333. PubMed ID: 28746979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study on the Role of Xpert MTB/RIF in Testing Different Types of Spinal Tuberculosis Tissue Specimens.
    Tang L; Feng S; Gao R; Han C; Sun X; Bao Y; Zhang W
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):722-726. PubMed ID: 29172708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.
    Ssengooba W; Gelderbloem SJ; Mboowa G; Wajja A; Namaganda C; Musoke P; Mayanja-Kizza H; Joloba ML
    Health Res Policy Syst; 2015 Jan; 13():4. PubMed ID: 25589057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.